RIGL
Rigel Pharmaceuticals Inc
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report2 of 8 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
+4.60%
vs ±12.9% implied · ×0.36
shaded = implied · ▲▼ = realized
No thesis.
Fund move
Fund move
Rigel Pharmaceuticals Inc
50.91
−0.54 · −1.04%
post 50.34 −1.13%
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $75.9M | 11.73% | +9.66% | |
| 2 | Soleus Capital ManagementSoleus | $72.1M | 11.15% | +18335.04% | |
| 3 | Armistice CapitalArmistice Capital | $65.4M | 10.11% | +30.63% | |
| 4 | State StreetState Streetindex-like | $40.7M | 6.29% | −7.16% | |
| 5 | Vanguard Capital ManagementVanguardindex-like | $30.7M | 4.75% | +2.74% | |
| 6 | American Century CompaniesAmerican Century Companies | $29.0M | 4.48% | +36.24% | |
| 7 | LSV Asset ManagementLSV | $28.2M | 4.36% | +19.98% | |
| 8 | Acadian Asset ManagementAcadian | $23.1M | 3.58% | −11.22% | |
| 9 | D. E. ShawD. E. Shaw | $21.2M | 3.28% | +21.73% | |
| 10 | Geode Capital ManagementGeodeindex-like | $18.9M | 2.92% | +9.66% | |
| 11 | Marshall WaceMarshall Wace | $14.4M | 2.22% | −38.60% | |
| 12 | CM ManagementCM Management | $9.8M | 1.51% | +6.38% | |
| 13 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $9.1M | 1.41% | +58.42% | |
| 14 | Dimensional Fund AdvisorsDimensional | $8.9M | 1.38% | −39.94% | |
| 15 | Goldman Sachs GroupGoldman Sachs | $8.9M | 1.37% | −48.35% | |
| 16 | Two Sigma InvestmentsTwo Sigma | $8.1M | 1.26% | −48.85% | |
| 17 | Delaware Management HoldingsDelaware | $7.6M | 1.18% | new | |
| 18 | Morgan StanleyMorgan Stanley | $7.3M | 1.12% | +88.18% | |
| 19 | Charles Schwab Investment ManagementCharles Schwabindex-like | $6.0M | 0.93% | −12.57% | |
| 20 | Northern TrustNorthern Trustindex-like | $5.7M | 0.89% | +8.78% | |
| 21 | Renaissance TechnologiesRenaissance Technologies | $5.7M | 0.88% | −56.91% | |
| 22 | O'shaughnessy Asset ManagementO'shaughnessy | $5.1M | 0.79% | +4.39% | |
| 23 | AQR Capital ManagementAQR | $4.9M | 0.75% | +37.13% | |
| 24 | Bridgeway Capital ManagementBridgeway | $4.9M | 0.75% | new | |
| 25 | NuveenNuveenindex-like | $4.8M | 0.75% | −63.26% |
154 managers report $647.0M of Rigel Pharmaceuticals on form 13F for the quarter ended Jun 30 '26. 26 of them hold 80% of it; BlackRock is largest at 11.73%.
Expected move
Inputs8Q avg ±11.0%·×0.99·fair
straddle ±12.8%
spot 51.31exp Nov 20ATM strike 50ATM straddle 7.75IV 79%